Stefan Scheler
Stefan Scheler publishes mostly in Molecular Biology, Pharmaceutical Science and Biomedical Engineering, on topics such as Protein purification and stability, Drug Solubulity and Delivery Systems and Advanced Drug Delivery Systems.
- World rank
- #3,965,156 of 7,710,434 ranked researchers
- Rank in Austria
- #24,134 of 43,330
- Works
- 33
- Citations
- 613
- Citations per work
- 18.6
What does Stefan Scheler research?
Stefan Scheler's work is mostly in Biochemistry, Genetics and Molecular Biology (24%), Pharmacology, Toxicology and Pharmaceutics (13%), Engineering (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1442.9%
- Everything else1134.4%
- Physical Sciences616.7%
- Engineering410.7%
- Materials Science26.0%
- Health Sciences26.0%
- Medicine26.0%
- 1Molecular Biology24% of their works
- 2Pharmaceutical Science13% of their works
- 3Biomedical Engineering11% of their works
- 4Radiology, Nuclear Medicine and Imaging6% of their works
- 5Biomaterials6% of their works
- 6Food Science6% of their works
Research topics
- Protein purification and stability
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Monoclonal and Polyclonal Antibodies Research
- Viral Infectious Diseases and Gene Expression in Insects
- Microfluidic and Capillary Electrophoresis Applications
- Innovative Microfluidic and Catalytic Techniques Innovation
- Proteins in Food Systems
Which keywords describe Stefan Scheler's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Biopharmaceuticals, Protein Aggregation, Glycosylation, Nanoparticles, Cyclodextrins and Solid Dispersions.
- Proteins
- Recombinant Protein
- Microfluidics
- Lab-on-a-Chip
- Fc Receptors
- Mucosal
- Solid Dispersions
- Nanoparticles
- Protein Aggregation
- Therapeutic Antibodies
- Monoclonal Antibodies
- Biopharmaceuticals
- Glycosylation
- Cyclodextrins
- Chitosan
- Antibody Engineering
- Droplet Formation
- Mammalian Cells
- Poly(dimethylsiloxane)
- Nanoemulsions
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Monoclonal Antibodies152 topics
- Therapeutic Antibodies152 topics
- Biopharmaceuticals111 topic
- Protein Aggregation111 topic
- Glycosylation72 topics
- Nanoparticles72 topics
- Cyclodextrins61 topic
- Solid Dispersions61 topic
- Chitosan51 topic
- Mucosal51 topic
- Antibody Engineering41 topic
- Fc Receptors41 topic
- Droplet Formation31 topic
- Lab-on-a-Chip31 topic
- Mammalian Cells31 topic
- Microfluidics31 topic
- Poly(dimethylsiloxane)31 topic
- Recombinant Protein31 topic
- Nanoemulsions21 topic
- Proteins21 topic
Where does Stefan Scheler work?
Stefan Scheler's main affiliation in the publication record is Bioforschung Austria, Austria.
How many publications and citations does Stefan Scheler have?
OpenAlex counts 33 works and 613 citations for Stefan Scheler, an h-index of 14, ranking #3,965,156 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Stefan Scheler. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.